Laboratory Corporation of America® Holdings (NYSE:LH) Files An 8-K

0

Laboratory Corporation of America® Holdings (NYSE:LH) today announced it will participate at the 2016 Credit Suisse Healthcare Conference. LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET).

A live audio webcast will be available via the Company website at www.labcorp.com and archived for replay.

 About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development services and technology-enabled solutions. With net revenue in excess of $8.5 billion in 2015 and more than 50,000 employees in approximately 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com. To learn more about LabCorp and LabCorp Diagnostics, visit www.labcorp.com.